Doximity, Inc. (DOCS)

NYSE: DOCS · Real-Time Price · USD
43.69
-0.09 (-0.21%)
At close: Dec 26, 2025, 4:00 PM EST
43.75
+0.06 (0.14%)
After-hours: Dec 26, 2025, 7:38 PM EST
-0.21%
Market Cap8.23B
Revenue (ttm)621.33M
Net Income (ttm)253.03M
Shares Out 188.27M
EPS (ttm)1.25
PE Ratio34.99
Forward PE27.46
Dividendn/a
Ex-Dividend Daten/a
Volume1,514,070
Open43.54
Previous Close43.78
Day's Range43.46 - 43.90
52-Week Range43.25 - 85.21
Beta1.38
AnalystsBuy
Price Target68.05 (+55.76%)
Earnings DateFeb 5, 2026

About DOCS

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]

Sector Healthcare
IPO Date Jun 24, 2021
Employees 830
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2024, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.

Financial Statements

Analyst Summary

According to 21 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $68.05, which is an increase of 55.76% from the latest price.

Price Target
$68.05
(55.76% upside)
Analyst Consensus: Buy
Stock Forecasts

News

HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inves...

2 days ago - PRNewsWire

Doximity: Elite Margins, AI Growth, And An Attractive Multiple

Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift f...

19 days ago - Seeking Alpha

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Doximity, Inc. ( DOCS) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Ch...

7 weeks ago - Seeking Alpha

Doximity Announces Fiscal 2026 Second Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, ...

7 weeks ago - Business Wire

Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to share...

2 months ago - Business Wire

Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...

2 months ago - Business Wire

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and di...

3 months ago - Business Wire

Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings

Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.

5 months ago - Benzinga

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Per...

5 months ago - Seeking Alpha

Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers

Doximity has acquired the AI startup Pathway Medical for $63 million.  Pathway has one of the largest structured datasets in medicine, Doximity said.

5 months ago - CNBC

Doximity Acquires Pathway, a Leader in AI Clinical Reference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based st...

5 months ago - Business Wire

Doximity Announces Fiscal 2026 First Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. ...

5 months ago - Business Wire

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...

5 months ago - Business Wire

Doximity: Slowing Sales And EBITDA Growth

Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...

5 months ago - Seeking Alpha

Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...

5 months ago - Business Wire

Doximity Crushes The Rule Of 40 - Try Rule Of 58

I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...

6 months ago - Seeking Alpha

Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'

I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...

6 months ago - Seeking Alpha

Doximity to Present at the William Blair 45th Annual Growth Stock Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...

7 months ago - Business Wire

Doximity Stock 7.8% Higher After Key Trading Signal

DOCS reverses steep decline after TradePulse Alert

7 months ago - Benzinga

These Analysts Cut Their Forecasts On Doximity After Q4 Results

Doximity, Inc. DOCS reported better-than-expected earnings for the fourth quarter on Thursday.

8 months ago - Benzinga

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.

Other symbols: AMATGLOB
8 months ago - Benzinga

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Fo...

8 months ago - Seeking Alpha

Doximity Stock Drops 20% After Outlook Disappoints

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

8 months ago - Investopedia

Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ende...

8 months ago - Business Wire

Doximity: Strong Fundamentals And Pharma Tailwinds Meet An Overpriced Valuation

Doximity is experiencing strong user engagement growth, driven by demand from medical prescribers and pharmaceutical marketers. Pharma marketing, Doximity's largest opportunity, is fueling sustained m...

8 months ago - Seeking Alpha